Global foam dressing market to reach USD 2.1 billion by 2026

San Francisco , May 31, 2022 /PRNewswire/ — A new market research report from Global Industry Analysts, Inc. (GIA), a leading market research firm, released today titled “Foam Dressings – Global Market Trajectories and Analysis”. The report offers a fresh perspective on the opportunities and challenges in the post-COVID-19 market that is undergoing significant transformation.

Global foam dressing market to reach USD 2.1 billion by 2026

Global foam dressing market to reach USD 2.1 billion by 2026

Facts at a Glance
What’s new in 2022?

  • Global Competitiveness and Percentage Market Share of Key Competitors

  • Market presence across multiple regions – strong/active/niche/insignificant

  • Online interactive peer-to-peer collaboration customization update

  • Access our digital archives and MarketGlass research platform

  • One year free update

Version: 8; release: April 2022
Executive pool: 1193
company: 103 – Players covered include 3M BSN Medical, Inc.; Essential Health; Coloplast; Convatech; Royal; Johnson & Johnson; Medline, Cardinal Health; Medtronic; Smith & Nephews; Winner Medical Group, Inc.
Coverage: All major regions and key areas
Market segments: Foam pore size (small, medium, large); wound type (surgical wounds, ulcers, trauma, burns, other wound types); end use (hospitals, specialist clinics, other end uses)
Geographical location: world; U.S.; Canada; Japan; China; Europe (France; Germany; Italy; U.K.; Spain; Russia; and the rest Europe); Asia Pacific (Australia; India; South Korea; and the rest Asia Pacific); Latin America (Argentina; Brazil; Mexico; and the rest Latin America); middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and the rest middle East); and Africa.

Free Project Preview – This is an ongoing global program. Preview our research program before you make a purchasing decision. We offer free access to qualified executives driving strategy, business development, sales and marketing, and product management roles at featured companies. The preview provides insider insights into business trends; competitive brands; profiles of domain experts; and market data templates, and more. You can also build your own custom reports using our MarketGlass™ platform, which provides thousands of bytes of data without purchasing our reports. Preview the registration form

Abstract-

During the COVID-19 crisis, the global foam dressing market is estimated at $1.7 billion By 2022, it is expected to reach the revised size $2.1 billion To 2026, to grow at a CAGR of 4.6% during the analysis period. By size, one of the segments analyzed in the report is expected to grow at a CAGR of 5.2%, while growth in the mid-size segment is rescaled to a revised CAGR of 4.5%. The market is expected to continue to grow with significant revenue growth owing to increasing demand for these dressings in postoperative, chronic, and acute wound management applications. Foam dressings utilize sterile polyurethane foam and a hydrocolloid adhesive for faster healing of wounds such as pressure ulcers, open wounds, burns, diabetic ulcers and venous ulcers. Rising geriatric population prone to chronic diseases, increasing incidence of chronic infections and diabetic wounds, and awareness of various benefits of advanced dressings are contributing to the growth of the foam dressing market.

The healthcare system bears the enormous burden associated with chronic wounds affecting approximately 6.5 million people, costing more than $50 billion every year in the United States. The problem is bound to become more complex with rising obesity and diabetes cases, a growing elderly population, the emergence of drug-resistant bacteria, and a limited number of antibiotics. The growing prevalence of lifestyle-related diseases, especially diabetes, is causing diabetic foot ulcers, pressure ulcers, and venous leg ulcers. The prevalence of these diseases is increasing every year. Delayed wound care is known to increase the risk of hospitalization, serious infection, and amputation. These challenges demonstrate the urgent need for advanced wound care protocols as well as effective strategies to address the potential surge in patients with untreated and untreated chronic wounds and related complications. Healthcare facilities are expected to witness a significant increase in the inflow of patients with severe chronic wounds, requiring professionals to consider aggressive and advanced treatments. This scenario demonstrates the need for proven wound care treatments and delivery of care in low-risk settings. Patients may be encouraged to seek high-quality wound care treatment in the hospital outpatient department or physician’s office to ensure uninterrupted access and risk reduction. Clinicians are expected to focus more on advanced wound care treatment solutions to reduce the risk of infection or amputation.

Foam dressings are highly effective and can improve patient outcomes by promoting the healing of different types of wounds, including diabetic foot ulcers. These products are expected to gain the attention of payers and patients as they reduce the downstream costs of managing and treating chronic diabetic wounds. Wound care is expected to benefit from ongoing efforts to improve healthcare infrastructure. Largely underserved and rural areas are characterized by high cases of lower extremity wounds due to difficult access to care services. The foam dressing market is expected to be driven by the growing adoption of these products in hospitals. Factors such as insufficient blood flow and nerve damage lead to various complications associated with diabetes, such as foot ulcers. This concern is highly relevant due to the increasing incidence of diabetes, with the US diabetic population exceeding the 34.2 million mark. The increasing number of cases of surgical wounds, diabetic foot ulcers, burns, and venous leg ulcers is driving the adoption of advanced wound care products in hospitals and is expected to increase the demand for wound care biologics and therapeutic devices.

The global demand for foam dressings is also driven by the increasing number of burn cases and road accidents, as well as the high incidence of pressure injuries in different age groups. Foam dressings are widely used in the clinical setting to treat pressure ulcers. The increased incidence associated with lifestyle diseases such as diabetes is expected to boost the global adoption of foam dressings to accelerate wound healing. The foam dressing market is benefiting from the growing demand for affordable care and treatment options for patients with acute and chronic wounds. The increasing use of foam dressings is also due to a substantial ongoing training program to educate medical professionals on advanced wound treatment solutions and dressings. The market growth is also attributed to the increasing awareness among physicians and patient groups regarding the availability and effectiveness of various such products. This awareness is being fostered by aggressive marketing campaigns by pharmaceutical companies and a positive attitude by customers to monitor their health status based on their desire for a better quality of life. Market players target physicians through various professional organizations, thought leaders, and accredited educational groups to educate them on the importance of timely wound management and the availability of various complex treatment alternatives. While awareness raising has yielded notable results in developed countries, it has yet to catch up in developing regions, mainly because the level of such marketing initiatives has dropped significantly in these regions. However, this may change in the coming years as wound management product companies increasingly compete for these untapped markets.

However, the expensive nature and insufficient reimbursement of various emerging countries remain major restraints for the market. Foam dressings also face problems due to a lack of proper scientific evidence for their effectiveness in eschar wounds and third-degree burns. On the other hand, the company’s continuous efforts to introduce better foam dressings are expected to bring new growth opportunities. To counter the negative effects of systemically administered analgesics, leading companies have come up with advanced pain-relieving dressings that combine moisture-balancing foam dressings that release low-dose NSAIDs such as ibuprofen. Some players in the market have introduced dressings with small pore size sterile polyvinyl alcohol foam. These developments are expected to boost the global demand for foam dressings. The expansion of the foam dressing market in the future will also be favored by the increasing number of surgical interventions, increasing awareness, and availability of innovative solutions.

North America It claims to hold a dominant share of the market owing to the rise in chronic wound incidents and large patient population.In the United States, chronic wounds affect more than 6.5 million people each year and are costly $25 billion on related treatments. The regional market is driven by the presence of leading players and the growing popularity of complex products. Foam dressings also benefit from the growing FDA approval of advanced kits for combination therapy. Moreover, marketing approvals for supportive products such as negative pressure wound therapy pumps are likely to further boost the market growth.On the other hand, the foam dressing market is Asia Pacific Substantial growth is expected in the coming years due to factors such as road accidents and chronic diseases leading to an increase in trauma and injury incidents across countries. The regional market will further benefit from the presence of a large number of diabetic patients, which is bound to generate demand for therapeutic foam dressings. more

MarketGlass™ Platform
Our MarketGlass™ platform is a free, full-stack knowledge hub that can be custom configured for the intelligent needs of today’s busy business executives! This influencer-driven interactive research platform is at the heart of our main research activities and draws on the unique perspectives of engaging executives around the world. Features include – Enterprise-wide peer-to-peer collaboration; Preview of research programs relevant to your company; 3.4 million domain expert profiles; Competitive company profiles; Interactive research modules; and secondary content create and publish blogs and podcasts; track domain events worldwide; and more. The client company will have full internal access to the project data stack. Currently used by more than 67,000 domain experts worldwide.

Our platform is free for qualified executives and can be accessed from our website www.StrategyR.com or via our just released mobile app iOS or android

About Global Industry Analysts, Inc. and StrategyR™
Global Industry Analyst Firm, (www.strategyr.com) is a renowned market research publisher and the only impact-driven market research firm in the world. Proudly serving more than 42,000 clients from 36 countries, GIA has been known for over 33 years for accurately forecasting markets and industries.

contact details:
Zach Ali
Corporate Communications Director
global industry analyst firm
Phone: 1-408-528-9966
www.StrategyR.com
Email: ZA@StrategyR.com

Link
Join our expert panel
https://www.strategyr.com/Panelist.asp

Connect with us on LinkedIn
https://www.linkedin.com/company/global-industry-analysts-inc./

Follow us on Twitter
https://twitter.com/marketbytes

Journalists and Media
Info411@strategyr.com

incision

incision

View original content download multimedia:https://www.prnewswire.com/news-releases/global-foam-dressings-market-to-reach-2-1-billion-by-2026–301557140.html

SOURCE GLOBAL INDUSTRY ANALYST COMPANY